Use of medicinal plants as the additional therapy of viral hepatitis
Journal Title: Актуальна інфектологія - Year 2017, Vol 5, Issue 3
Abstract
Dear colleagues, continuing the rubric of the journal about the treatment of infectious diseases by medicinal plants, we want to present the methods of using medicinal plants as an additional therapy for treatment of viral hepatitis in addition to the main treatment according to the generally clinical standards of antiviral therapy. Viral hepatitis compiles a large group of human infectious diseases characterized by a predominant liver damage. “Currently, viral hepatitis is recognized as a major public health problem requiring urgent action”, said Dr Margaret Chan, WHO Director-General (WHO Global hepatitis report, 2017). Treatment of viral hepatitis is a complex task and involves the use of generally clinical recommendations or standards. There are criteria for determining the need for pharmacotherapy and the most rational scheme for antiviral treatment in every case of viral hepatitis. The purpose of antiviral therapy is to achieve a stable virologic response, to prevent the progression of the disease, the development of cirrhosis and hepatocellular carcinoma. However, at the present stage a stable virologic response in the general population of patients can be achieved in approximately 60 % of cases. In addition, standard antiviral drugs have side effects, are of high cost and are contraindicated in a number of clinical situations, for example, with a decrease in the number of blood elements (thrombocytopenia, leukopenia, anemia), at the stage of decompensated liver cirrhosis. Probably, all this induces to use alternative methods of therapy, which remain popular both among general practitioners and patients with this infection. The question of the treatment of viral hepatitis with medicinal herbs has been studied for a long time. According to some authors, there is no scientific evidence that hepatitis C can be cured by herbs. The only scientifically proven method of fighting the virus is antiviral therapy. However, there are other points of view on this issue. A review of the results of randomized trials on the effectiveness of drugs containing herbs in the treatment of hepatitis C and the advisability of their use in this category of patients found that in 2001 a review was published on the analysis of the efficacy and safety of hepatitis C treatment with drugs based on medicinal herbs (Yarnell E., Abascal K. and others). The authors turned to the register of controlled studies of the hepatobiliary Cochrane group, the Cochrane libraries, MEDLINE, Embase, BIOSIS, and also to Chinese and Japanese databases. For the analysis, randomized clinical trials were selected comparing the results of using medicinal herbs (one herb or herb collection) with placebo or no treatment, or with general nonspecific treatment, other methods of phytotherapy or with interferon α (IFN-α) and/or ribavirin. Analysis of randomized clinical trials has shown a proven positive role in the treatment of viral hepatitis following such medicinal herbs as: traditional Chinese herbs, Sophora Japanese (Milk thistle, Silybum marianum), Licorice (Liquorice, sweetwood, licorice root), Andrographis paniculata, St. John’s wort (Hypericum perforatum), Chinese Schisandra chinensis (wu wei zi), Astragalus membranaceus root (huang qi), dandelion root (Taraxacum officinale), root of the great burdock (Arctium lappa), Curcuma longa, root of the red sage (or danshen, Salvia miltiorrhiza), etc. The authors of this article based on available literature data recommend the plant groups used in the treatment of viral hepatitis, principles, as well as prescription of plant collections, the method of preparation and recommendations for the application of the prepared preparations with indication of the dose, the frequency of administration and the duration of phytotherapy for this group of patients. It is indicated at which stage of the disease and which herbs can be added to the collection, depending on the general state and complains of the patient, the causative agent of viral hepatitis and laboratory examination data. For the therapy of viral hepatitis, it was recommended to use medicinal herbs only as an addition to the main treatment with antiviral drugs according to clinical recommendations or standards for the treatment of viral hepatitis.
Authors and Affiliations
I. B. Ershova, T. F. Osypova
Keywords
Related Articles
- EP ID EP222214
- DOI 10.22141/2312-413x.5.3.2017.109859
- Views 111
- Downloads 0
Change in functional hepatic tests during pregnancy
Liver diseases associated with pregnancy occur in about 3 % of pregnant women and are an important cause of both maternal and fetal mortality. In recent years, important data on the pathogenesis, diagnosis and treatment...
Liver Fibrosis: Current Principles of Diagnosis
Liver fibrosis — a natural consequence of almost all liver diseases of any origin. We are faced with a number of standard stereotype processes that take place in the liver tissue. Mostly it is the processes of chronic in...
Optimization of Educational Process and Clinical Management of Profile Patients by Foreign Students at the epartment of Infectious Diseases and Epidemiology of the Higher State Educational Institution of Ukraine Bukovinian State Medical University»
The article highlights some aspects of optimization of educational process when teaching subjects «Tropical medicine and clinical parasitology», «Infectious disease» for foreign students with English language of studying...
Treatment Success in Patients with Drug-Resistant Pulmonary Tuberculosis in Cavitation of S6 of Lungs and Concomitant Endobronchial Pathology Using Isoniazid-Hydroxymethylquinoxalinedioxyde in the Comprehensive Treatment
Introduction. Improving the efficiency of treatment of patients with drug-resistant pulmonary tuberculosis in cases of cavitation in the S6 of lungs and concomitant endobronchial pathology. Objective of the study: to exa...
Cytomegalovirus infection in children: diagnostic difficulties
This article summarizes literature data about the problem of cytomegalovirus infection in children. It serves to generalize modern complications and outcomes. Article also considers the methods of rational diagnosis of...